Mar 23, 2023 04:25 AM

BUSINESS

China Clears First Homegrown mRNA Covid Vaccine

By Zhao Jinzhao and Han Wei

CSPC said in an earnings report that it established production facilities and self-sufficiency of critical raw materials and auxiliary materials for the new mRNA vaccine.

CSPC said in an earnings report that it established production facilities and self-sufficiency of critical raw materials and auxiliary materials for the new mRNA vaccine.

China approved its first homegrown Covid-19 vaccine using the advanced mRNA technology, months after the country pivoted from its “zero-Covid” strategy toward living with the virus.

The vaccine, developed by CSPC Pharmaceutical Group Ltd., was approved for emergency use by the National Medical Products Administration, Hong Kong-traded CSPC said Wednesday in a statement.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Pests on the Plateau

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin-Sinica Business Brief: China’s First Homegrown Jet Sets Sights on Airbus and Boeing

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s Tobacco Monopoly Is Swept Up in Corruption Probes

2: China’s Factory Activity Gets Back to Growth, but Recovery Remains Patchy, Caixin PMI Shows

3: China’s EV Industry Calls on Regulators to Curb the Back-Seat Driving

4: In Depth: China’s Proposed New Curbs on Private Securities Funds Spark Controversy

5: China’s Services Sector Continues to Rebound Faster Than Industrial Sector

SPONSORED

OR